首页> Oral oncology> Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis.

Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Joshua D,Palmer

第一单位： Department of Radiation Oncology, The James Cancer Hospital at The Ohio State University, Columbus, OH, United States.

作者： Joshua D,Palmer ^[1] ; Charles J,Schneider ^[2] ; Neil,Hockstein ^[3] ; Alexandra L,Hanlon ^[4] ; Jordan,Silberg ^[1] ; Jon,Strasser ^[5] ; Elizabeth A,Mauer ^[4] ; Michael,Dzeda ^[5] ; Robert,Witt ^[3] ; Adam,Raben ^[6]

作者单位： Department of Radiation Oncology, The James Cancer Hospital at The Ohio State University, Columbus, OH, United States. ^[1] Department of Medical Oncology, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE, United States. ^[2] Section of Otolaryngology - Head and Neck Surgery, Department of Surgery, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE, United States. ^[3] Department of Nursing, University of Pennsylvania, Philadelphia, PA, United States. ^[4] Department of Radiation Oncology, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE, United States. ^[5] Department of Radiation Oncology, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE, United States. Electronic address: ARaben@christianacare.org. ^[6]

关键词 Cetuximab Cutaneous squamous cell carcinoma Head and neck Post-operative radiotherapy Survival